Cell-free microRNAs as diagnostic, prognostic, and predictive biomarkers for lung cancer.
about
Targeting the epigenome in lung cancer: expanding approaches to epigenetic therapyEmerging blood-based biomarkers for detection of gastric cancerCirculating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and reviewEpigenetics of lung cancerMethodological challenges in utilizing miRNAs as circulating biomarkersCirculating Plasma MicroRNAs As Diagnostic Markers for NSCLCEarly lung cancer diagnosis by biosensors.MYLK and MYL9 expression in non-small cell lung cancer identified by bioinformatics analysis of public expression data.MicroRNA-146a affects the chemotherapeutic sensitivity and prognosis of advanced gastric cancer through the regulation of LIN52MicroRNAs as potential biomarkers for gastric cancer.Acquisition of radioresistance in docetaxel-resistant human lung adenocarcinoma cells is linked with dysregulation of miR-451/c-Myc-survivin/rad-51 signaling.Effects of preanalytic variables on circulating microRNAs in whole blood.The non-coding RNAs of the H19-IGF2 imprinted loci: a focus on biological roles and therapeutic potential in Lung Cancer.Expression of miR-148/152 family as potential biomarkers in non-small-cell lung cancerCirculating miRNAs is a potential marker for gefitinib sensitivity and correlation with EGFR mutational status in human lung cancers.High copy number variation of cancer-related microRNA genes and frequent amplification of DICER1 and DROSHA in lung cancer.Circulating nucleic acids in plasma and serum (CNAPS): applications in oncology.Circulating cell-free microRNA as biomarkers for screening, diagnosis and monitoring of neurodegenerative diseases and other neurologic pathologiesMiR-146a-5p inhibits cell proliferation and cell cycle progression in NSCLC cell lines by targeting CCND1 and CCND2.A six-microRNA panel in plasma was identified as a potential biomarker for lung adenocarcinoma diagnosis.Epigenetic biomarkers in laboratory diagnostics: emerging approaches and opportunities.Moving RNA moves RNA forward.miRNAs as non-invasive biomarkers for lung cancer diagnosis.MicroRNAs: a new key in lung cancer.Clinical Aspect of MicroRNA in Lung Cancer.Universal screening test based on analysis of circulating organ-enriched microRNAs: a novel approach to diagnostic screening.Long non-coding RNA functions in lung cancer.Dysregulation and diagnostic potential of microRNA in Alzheimer's disease.Hypoxia-induced microRNA-301b regulates apoptosis by targeting Bim in lung cancer.MiR-181a-5p inhibits cell proliferation and migration by targeting Kras in non-small cell lung cancer A549 cells.A simple and highly sensitive fluorescence assay for microRNAs.miR-137 impairs the proliferative and migratory capacity of human non-small cell lung cancer cells by targeting paxillin.Regulatory role of small nucleolar RNAs in human diseases.Associations of mRNA:microRNA for the Shared Downstream Molecules of EGFR and Alternative Tyrosine Kinase Receptors in Non-small Cell Lung Cancer.Further the liquid biopsy: Gathering pieces of the puzzle of genometastasis theory.Systematic review and critique of circulating miRNAs as biomarkers of stage I-II non-small cell lung cancer.Salivary miRNA panel to detect HPV-positive and HPV-negative head and neck cancer patients.MicroRNAs: A novel potential biomarker for diagnosis and therapy in patients with non-small cell lung cancer.Aberrant methylation of mutL homolog 1 is associated with increased risk of non-small cell lung cancer.Association between ERCC2 Lys751Gln polymorphism and lung cancer risk: a meta-analysis involving 23,370 subjects.
P2860
Q24609974-F93C3525-CF88-43AB-A268-25F45180700DQ26778026-00D3EAB4-91B9-491B-8153-0CA7EF561085Q26785539-C6E3A5EC-0EB5-45DA-8764-1C25132C08AAQ26996766-90A3519A-AC91-4532-9FBB-2598B52E0421Q27027950-D58D5094-5898-4EC8-BECD-A008711087E0Q28073562-874E44F6-2910-41DF-B868-742BD3775A46Q30449799-72B3D565-A4E5-445A-AF1C-0A0028EA3D28Q30847076-65773621-7320-4311-AEF8-24BEA3303DCFQ33598225-B1BF6A48-C00E-4809-B24F-95584462F7ADQ34168445-F98D73E3-254F-4FE1-A272-9ECAFAC67EB4Q34227615-16D5EE36-E2D6-4919-A228-3A54D00ADFFEQ34635975-841317D8-8B61-49AC-8C20-F6452BB1FC15Q35425128-C7BFC679-22CF-42B7-B2C5-D49139CE739BQ35565052-B07D3CEA-31D3-4ADA-BB68-BED62A4D41F1Q35835222-600D15F4-5DC7-4F6E-A170-F2BF6EADA8AAQ36414198-EDD5665A-62D6-4994-AEED-5EDE1AB46764Q37014663-8F5E136F-80C9-4427-924B-B0DBE7E76AD5Q37158033-FD55607A-5FB4-4AC5-BBCE-5D41B0DE4374Q37644858-12EABCDD-E92C-486C-A43D-D7B797A6FBD4Q37701630-829A5444-F348-4DD6-B078-2DB256324EE6Q38115622-B9D6824B-38F4-4AC6-A022-EF330EDE4519Q38134570-DC53714F-9FCE-441D-80CD-6E920A840401Q38221221-F55E6C21-AE87-4D2D-8980-0F8BA251D22BQ38241121-9CAB34A0-5B2D-4CF3-9581-74ACCEDD0FCAQ38252575-2AAF5D5D-A3D2-4369-ADD1-9A073989CE38Q38263664-F912B8EB-F498-41C7-B292-0F5E51D68614Q38431140-BD92DEE7-EC57-48BA-96C3-6248FD8E571BQ38612032-27F1696D-0C73-4EC1-911A-03AE15BC16B1Q38761203-55769BC3-A775-4038-A108-3E0A96A0D36EQ38858703-5BDD0E78-39F4-4176-B390-2B686C156E88Q38912650-6575E1B7-41D7-4A43-9CAC-540324542F86Q39062167-81695BD2-3FEC-4D11-98D7-8295ECC2B83EQ40550308-8F48D54E-B817-4170-A724-80EE3864C3E5Q41444378-C744FABE-4C61-428D-AC2C-62D417E9B2DEQ42702940-9105EA7C-A677-4952-A33E-723FCF64BFF6Q47106442-9C619A1B-592F-4861-A83E-F93286F26050Q47112739-6BE48C6F-7468-4D29-81F2-049C1A1214B3Q47663124-52DD58E5-2585-4954-BA80-450D8DB4A63EQ47807283-25959DC9-D1BD-4176-B068-669B6D555478Q53136965-74A5E0E6-F15E-4B5A-96DA-9C5A018875A2
P2860
Cell-free microRNAs as diagnostic, prognostic, and predictive biomarkers for lung cancer.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Cell-free microRNAs as diagnostic, prognostic, and predictive biomarkers for lung cancer.
@en
type
label
Cell-free microRNAs as diagnostic, prognostic, and predictive biomarkers for lung cancer.
@en
prefLabel
Cell-free microRNAs as diagnostic, prognostic, and predictive biomarkers for lung cancer.
@en
P2093
P2860
P356
P1476
Cell-free microRNAs as diagnostic, prognostic, and predictive biomarkers for lung cancer
@en
P2093
Artūrs Ābols
Diāna Andrējeva
Elīna Zandberga
Gunta Purkalne
Viktors Kozirovskis
P2860
P304
P356
10.1002/GCC.22032
P50
P577
2012-12-10T00:00:00Z